Nuzenio

Respiratory Syncytial Virus

Respiratory Syncytial Virus news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 11 publisher sources 100/100 entity strength

Latest news

RSV-B Resistance to Nirsevimab Detected in Breakthrough Infections - EMJEMJ · Mon, 10 Aug 2026 09:08:29 GMTRSV hits hard as calls for vaccine funding grow - The PressThe Press · Sun, 09 Aug 2026 16:00:00 GMTParents urged to vaccinate children amid flu, Covid-19 and RSV infection cases - South China Morning PostSouth China Morning Post · Sat, 08 Aug 2026 08:50:36 GMTFDA Reviews Clesrovimab for Second-Season RSV Prevention in High-Risk Children - Patient Care OnlinePatient Care Online · Sat, 08 Aug 2026 02:54:59 GMTClesrovimab shows comparable safety to palivizumab in high-risk infants across 2 RSV seasons - Contemporary PediatricsContemporary Pediatrics · Fri, 07 Aug 2026 17:56:30 GMTUS FDA accepts supplemental Biologics License Application for Merck’s Enflonsia - PMLiVEPMLiVE · Fri, 07 Aug 2026 10:55:00 GMTRespiratory syncytial virus (RSV) older adults vaccination coverage in England: June 2026 report - GOV.UKGOV.UK · Thu, 06 Aug 2026 23:19:44 GMTFDA Accepts Merck's Application to Expand Enflonsia into Second RSV Season - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 16:59:38 GMT

Timeline

Mon, 10 Aug 2026 09:08:29 GMTRSV-B Resistance to Nirsevimab Detected in Breakthrough Infections - EMJ
Sun, 09 Aug 2026 16:00:00 GMTRSV hits hard as calls for vaccine funding grow - The Press
Sat, 08 Aug 2026 08:50:36 GMTParents urged to vaccinate children amid flu, Covid-19 and RSV infection cases - South China Morning Post
Sat, 08 Aug 2026 02:54:59 GMTFDA Reviews Clesrovimab for Second-Season RSV Prevention in High-Risk Children - Patient Care Online
Fri, 07 Aug 2026 17:56:30 GMTClesrovimab shows comparable safety to palivizumab in high-risk infants across 2 RSV seasons - Contemporary Pediatrics
Fri, 07 Aug 2026 10:55:00 GMTUS FDA accepts supplemental Biologics License Application for Merck’s Enflonsia - PMLiVE

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Respiratory Syncytial Virus.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.